Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Granulocyte-macrophage colony-stimulating factor (GM-CSF): A variety of possible applications in clinical medicine

  • 29 Accesses

  • 4 Citations

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Martin, F. H., Suggs, S. V., Langley, K. E., Lu, H. S., Ting, J., Okino, K. H., Morris, C. F., McNiece, I. K., Jacobsen, F. W., Mendiaz, E. A., Birkett, N. C., Smith, K. A., Johnson, M. J., Parker, V. P., Flores, J. C., Patel, A. C., Fisher, E. F., Erjavec, H. O., Herrera, C. J., Wypych, J., Sachdev, R. K., Pope, J. K., Leslie, I., Wen, D., Lin, C.-H., Cupples, R. L., Zsebo, K. M. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 63 (1990) 203–211.

  2. 2.

    Anderson, D. M., Lyman, S. D., Baird, A., Wignall, J. M., Eisenman, J., Rauch, C., March, C. J., Boswell, H. S., Gimpel, S. D., Cosman, D., Williams, D. E. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63 (1990) 235–243.

  3. 3.

    Sieff, C. A. New hats for hematopoietic hormones. Exp. Hematol. 19 (1991) 857–860.

  4. 4.

    Eschbach, J. W., Kelly, M. R., Haley, N. R., Abels, R. I., Adamson, J. W. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N. Engl. J. Med. 321 (1989) 158–163.

  5. 5.

    Halpérin, D. S., Félix, M., Wacker, P., Lacourt, G., Babel, J.-F., Wyss, M. Recombinant human erythropoietin in the treatment of infants with anaemia of prematurity. Eur. J. Pediatr. 151 (1992) 661–667.

  6. 6.

    Duc, G. Erythropoietin and anaemia of prematurity. (Editor's comment). Eur. J. Pediatr. 151 (1992) 667.

  7. 7.

    Groopman, J. E., Mitsuyasu, R. T., DeLeo, M. J., Oette, D. H., Golde, D. W. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 317 (1987) 593–598.

  8. 8.

    Lieschke, G. J., Burgess, A. W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. (First of two parts). N. Engl. J. Med. 327 (1992) 28–35.

  9. 9.

    Lieschke, G. J., Burgess, A. W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. (Second of two parts). N. Engl. J. Med. 327 (1992) 99–106.

  10. 10.

    Herrmann, F. G-CSF: Status quo and new indications. Infection 20 (1992) 183–188.

  11. 11.

    Weiss, M., Yetz-Aldape, J., Crosier, P. S., Nathan, D. G., Sieff, C. A. Committed hematopoietic progenitors of human bone marrow are restricted to the CD38 + 34 + fraction whereasc-kit expression is greatest in CD38-34 + cells. Blood 78 (1991) 161 a — (abstract 634).

  12. 12.

    Ganser, A., Völkers, B., Greher, J., Ottmann, O. G., Walther, F., Becher, R., Bergmann, L., Schulz, G., Hoelzer, D. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes — a phase I/II trial. Blood 73 (1989) 31–37.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Weiss, M., Belohradsky, B.H. Granulocyte-macrophage colony-stimulating factor (GM-CSF): A variety of possible applications in clinical medicine. Infection 20, S81–S83 (1992). https://doi.org/10.1007/BF01705023

Download citation